Evidence map›Paper›PMID 37441467›Full record

ArticleKidney international reports2023

Randall-Type Monoclonal IgE Kappa Light-Heavy Chain Deposition Disease.

Pierre Isnard, Nicolas Benichou, David Sibon, Alexia Rinsant, Jean-Michel Goujon, Guy Touchard, Cécile Ory, Sihem Kaaki, Magali Colombat, Laura Do Souto Ferreira and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pierre IsnardDepartment of Pathology, Necker Hospital, APHP, Université Paris Cité, Paris, France.
Nicolas BenichouDepartment of Nephrology, Georges Pompidou European Hospital, APHP, Université Paris Cité, Paris, France.
David SibonLymphoid Malignancies Department, Henri Mondor University Hospital, APHP, Créteil, Paris-Est Créteil University, France.
Alexia RinsantDepartment of Pathology, Center Hospitalier Universitaire de Poitiers, Center National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Université de Poitiers, Poitiers, France.
Jean-Michel GoujonDepartment of Pathology, Center Hospitalier Universitaire de Poitiers, Center National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Université de Poitiers, Poitiers, France.
Guy TouchardDepartment of Pathology, Center Hospitalier Universitaire de Poitiers, Center National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Université de Poitiers, Poitiers, France.
Cécile OryDepartment of Pathology, Center Hospitalier Universitaire de Poitiers, Center National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Université de Poitiers, Poitiers, France.
Sihem KaakiDepartment of Pathology, Center Hospitalier Universitaire de Poitiers, Center National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Université de Poitiers, Poitiers, France.
Magali ColombatDepartment of Pathology, University Hospital of Toulouse, University Cancer Institute of Toulouse, Toulouse, France.
Laura Do Souto FerreiraUnite de Génomique du Myelome, IUC-Oncopole, University Hospital Toulouse, Toulouse, France.
Hervé Avet-LoiseauUnite de Génomique du Myelome, IUC-Oncopole, University Hospital Toulouse, Toulouse, France.
Alexandre KarrasDepartment of Nephrology, Georges Pompidou European Hospital, APHP, Université Paris Cité, Paris, France.
Frank BridouxDepartment of Nephrology, Center Hospitalier Universitaire de Poitiers, Center National de Référence Maladies Rares: Amylose AL et Autres Maladies à Dépôts d'Immunoglobulines Monoclonales, Université de Poitiers, Poitiers, France.
Marion RabantDepartment of Pathology, Necker Hospital, APHP, Université Paris Cité, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IgELHCDDMIDD

Identifiers

PMID37441467
PMCPMC10334351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.